Is it too soon for Mesenchymal Stem Cell trials in people with ALS?

ArticleinAmyotrophic Lateral Sclerosis 9(6):321-2 · October 2008with6 Reads
Impact Factor: 2.37 · DOI: 10.1080/17482960802425559 · Source: PubMed

    Abstract

    Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting primarily the motor neurons. Stem cell therapy is under development as a possible treatment approach. A pilot study of intraspinal injections of mesenchymal stem cells (MSC) was conducted in 9 participants. We review this paper, the rationale, preclinical data and study design.